Codes ATC:
L01CD01
Indication
Other specified malignant neoplasms of bronchus or lung
Code ICD11:
2C75.Y
INN
Paclitaxel
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
Formulations
Parenteral > General injections > IV:
6 mg per mL
Historique des statuts LME
Ajouté pour la première fois en 2015
(TRS
994)
Sexe
Tous
Âge
Adolescents et adultes
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
In 2015, as part of the comprehensive review of cancer medicines undertaken by the Expert Committee, listing for paclitaxel on the complementary list of the EML for use in treatment protocols for non-small cell lung cancer was specifically endorsed. The relevant extract from TRS994 regarding the Expert Committee's 2015 consideration of treatment protocols for non-small cell lung cancer is attached.